CMPX
Compass Therapeutics Inc.
1.10$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | +0.4% | -1.1% | – | – | – | – | – | – | – | -0.5% | – | – | |
| – | – | -119.5% | – | – | – | – | – | – | – | – | – | – | |
| – | +40.7% | -23.4% | +17.3% | -22.9% | +51.4% | +0.1% | +25.7% | -21.9% | +6.6% | -2.2% | +46.4% | – | |
| – | -4.1% | +9.5% | +45.4% | -23.2% | -2.5% | +38.9% | -5.3% | -35.7% | +44.3% | +60.1% | +7.2% | – | |
| – | +29.1% | -17.0% | +24.5% | -23.0% | +35.4% | +8.4% | +17.3% | -24.9% | +11.4% | +13.1% | +35.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +270.7% | -77.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.